Detalhe da pesquisa
1.
MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling.
Cell;
154(2): 311-324, 2013 Jul 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23830207
2.
Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner.
Cell;
144(2): 187-99, 2011 Jan 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21241890
3.
Regulatory Mechanism of MicroRNA Expression in Cancer.
Int J Mol Sci;
21(5)2020 Mar 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32138313
4.
miR-218 and miR-129 regulate breast cancer progression by targeting Lamins.
Biochem Biophys Res Commun;
496(3): 826-833, 2018 02 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29378184
5.
MicroRNAs in the pathogenesis of myelodysplastic syndromes and myeloid leukaemia.
Curr Opin Hematol;
21(4): 276-82, 2014 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24870972
6.
The correlation between the expression of ubiquitin-conjugating enzyme 2C and prostate cancer prognosis.
J Cancer Res Clin Oncol;
149(9): 6351-6360, 2023 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36752909
7.
The Correlations between the Intensity of Histopathological Ubiquitin-Specific Protease 11 Staining and Progression of Prostate Cancer.
Pharmaceuticals (Basel);
16(12)2023 Dec 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38139829
8.
The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex.
EMBO J;
27(13): 1863-74, 2008 Jul 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18566590
9.
The equilibrium of tumor suppression: DUBs as active regulators of PTEN.
Exp Mol Med;
54(11): 1814-1821, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36385557
10.
The Positive Correlations between the Expression of Histopathological Ubiquitin-Conjugating Enzyme 2O Staining and Prostate Cancer Advancement.
Pharmaceuticals (Basel);
14(8)2021 Aug 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34451875
11.
NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis.
Cell Metab;
33(12): 2380-2397.e9, 2021 12 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34879239
12.
Interplay between c-Src and the APC/C co-activator Cdh1 regulates mammary tumorigenesis.
Nat Commun;
10(1): 3716, 2019 08 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31420536
13.
A muscle-specific UBE2O/AMPKα2 axis promotes insulin resistance and metabolic syndrome in obesity.
JCI Insight;
4(13)2019 07 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31292296
14.
PTEN self-regulates through USP11 via the PI3K-FOXO pathway to stabilize tumor suppression.
Nat Commun;
10(1): 636, 2019 02 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30733438
15.
Role of the tumor suppressor RASSF1A in Mst1-mediated apoptosis.
Cancer Res;
66(5): 2562-9, 2006 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16510573
16.
New Insights into the Role of E2s in the Pathogenesis of Diseases: Lessons Learned from UBE2O.
Mol Cells;
41(3): 168-178, 2018 Mar 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29562734
17.
MicroRNA, an Antisense RNA, in Sensing Myeloid Malignancies.
Front Oncol;
7: 331, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29441324
18.
A new duet in cancer biology: AMPK the typical and UBE2O the atypical.
Mol Cell Oncol;
4(3): e1304846, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28616582
19.
A UBE2O-AMPKα2 Axis that Promotes Tumor Initiation and Progression Offers Opportunities for Therapy.
Cancer Cell;
31(2): 208-224, 2017 02 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28162974
20.
The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function.
Cancer Discov;
7(4): 424-441, 2017 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28174173